Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Visudyne Medicare Coverage Denial Disputed In Lawsuit

Executive Summary

A lawsuit challenging the denial of Medicare coverage for QLT/Novartis' Visudyne could compel CMS to establish an appeals process for all National Coverage Determinations

You may also be interested in...



Visudyne Medicare Settlement: CMS Cmte To Review Occult Lesion Data

CMS' Medicare Coverage Advisory Committee will review initial data from QLT's Phase III trial of Visudyne (verteporfin) for age-related macular degeneration patients with occult lesions

Visudyne Medicare Settlement: CMS Cmte To Review Occult Lesion Data

CMS' Medicare Coverage Advisory Committee will review initial data from QLT's Phase III trial of Visudyne (verteporfin) for age-related macular degeneration patients with occult lesions

Medicare Coverage Policy Could Stand Despite Successful Appeal – CMS Rule

A successful challenge of a national or local Medicare coverage determination would not necessarily reverse the policy for all beneficiaries, a 1CMS proposed rule says

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel